0 CHECKOUT

PRODUCT FILTERS

REGION

18
4
3
3
3

COUNTRY

PRICE

30
51
131
150

PUBLISHED

0
8
58
150

PRODUCT TYPE

136
8
4
2

Lymphoma Drugs Market Research Reports

Lymphoma encompasses a variety of blood cancers of the lymphatic system. Non-Hodgkin’s Lymphoma (NHL) for example, is diagnosed in over 100,000 every year in the US and EU combined. An array of expert reports in our Lymphoma Section enable you to investigate drug development strategies and market trends for NHL, Hodgkin’s Lymphoma, Skin Lymphoma, T-Cell Lymphoma, Indolent Lymphoma and other variants. Investigate key issues such as licensing, R&D, industry alliances, generic drugs (rituximab, bortezomib, doxorubicin, bleomycin, vinblastine, etc.) and the activities of major pharmaceutical players such as Bristol-Myers Squibb, GlaxoSmithKline, Hoffmann-La Roche, and Sanofi-Aventis. Show Less Read more

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales,...

Published:  March 2016
Price:  From

Indolent Lymphoma - Pipeline Review, H1 2016

Indolent Lymphoma - Pipeline Review, H1 2016 Summary ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape. The report provides comprehensive...

Published:  February 2016
Price:  From

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Lymphoblastic Lymphoma-Pipeline Insights, 2016

“ Lymphoblastic Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Lymphoblastic Lymphoma. The report covers the product...

Published:  March 2016
Price:  From

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016

“ B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the B-Cell Non-Hodgkin Lymphoma. The report covers the...

Published:  March 2016
Price:  From

Mycosis Fungoides-Pipeline Insights, 2016

“ Mycosis Fungoides-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Mycosis Fungoides. The report covers the product profiles...

Published:  March 2016
Price:  From

B-Cell Lymphomas-Pipeline Insights, 2016

“ B-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the B-Cell Lymphomas. The report covers the product profiles in...

Published:  March 2016
Price:  From

Waldenstrom Macroglobulinemia-Pipeline Insights, 2016

“ Waldenstrom Macroglobulinemia-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Waldenstrom Macroglobulinemia. The report covers...

Published:  March 2016
Price:  From

T-Cell Lymphomas-Pipeline Insights, 2016

“ T-Cell Lymphomas-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the T-Cell Lymphomas. The report covers the product profiles in...

Published:  March 2016
Price:  From

Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Mycosis Fungoides-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Mycosis Fungoides-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Mantle Cell Lymphoma - Pipeline Review, H1 2016

Mantle Cell Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Mantle Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape. The report...

Published:  February 2016
Price:  From

Hodgkin Lymphoma - Pipeline Review, H1 2016

Hodgkin Lymphoma - Pipeline Review, H1 2016 Summary The report ‘Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Hodgkin Lymphoma pipeline landscape. The report provides...

Published:  February 2016
Price:  From

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016 Summary The report ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2016’, provides an overview of the Anaplastic Large...

Published:  February 2016
Price:  From

Target Atlas in Lymphoma: A Competitive Outlook

Extra value: One year of free online updates included with this product "Target Atlas in Lymphoma: A Competitive Outlook" helps you to understand the complex world of commercial development in lymphoma...

Published:  February 2016
Price:  From

Lymphoma Drug Pipeline Update

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 369 companies plus partners developing 521 lymphoma drugs in 949 developmental projects in cancer....

Published:  February 2016
Price:  From
Loading Indicator

Our Clients